IPO, Mergers and Acquisitions and Public Trading

Sports Investment Banking: How to Win the Super Bowl and the World Cup in the Same Year

Mergers and Inquisitions

DECEMBER 4, 2024

Sports Investment Banking Definition: In sports IB, bankers advise on equity and debt issuances, mergers, acquisitions, and restructuring deals for sports teams and leagues, sports-adjacent technology and services firms, and facilities such as arenas, stadiums, and racetracks. What is Sports Investment Banking?

Investment Banking

Investment Banking Bank Banking Investment

Upgrade acquires travel-focused BNPL startup Uplift for a song

TechCrunch: M&A

JULY 27, 2023

Meanwhile, publicly traded BNPL companies like Affirm and Australia’s Zip have seen their share prices plummet; Affirm was recently forced to shut down its crypto unit and lay off 19% of its staff. million users to the platform, and comes as Upgrade weighs an IPO. billion to just $6.7

Finance

Finance Finance IPO Debt

Will There Be an IPO for a Specialty Consulting Company in 2024?

Focus Investment Banking

JANUARY 18, 2024

In that environment, very few firms sought IPOs, and there was a major slowdown in overall exits, whether private or public. And will that mean that some of the privately held management consulting firms or other professional services companies will choose an IPO this year? Contact Kelly at Kelly.Kittrell@focusbankers.com.

IPO

IPO Consulting Corporate Finance Professional Services

MergersCorp Expands Services to SPAC Companies Amid Growing Market Demand

MergersCorp M&A International

OCTOBER 15, 2024

In a significant move to capitalize on the burgeoning Special Purpose Acquisition Company (SPAC) market, MergersCorp has announced the launch of specialized services tailored specifically for SPACs. This innovative approach has attracted substantial interest from investors, entrepreneurially minded companies, and financial institutions alike.

Mergers and Acquisitions

Mergers and Acquisitions Advisory IPO Initial Public Offering

Investment Banking – Meaning, Functions and More

Razorpay

JULY 27, 2023

Investment banking is a branch of banking that organizes and enables large, complex financial transactions for businesses, like mergers, IPOs or underwriting. Investment Banks help businesses plan and strategize their IPO to ensure success. Investment Banks help businesses plan and strategize their IPO to ensure success.

Investment Banking

Investment Banking Bank Banking Investment

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Cooley M&A

OCTOBER 29, 2020

is the increased frequency at which SPAC IPOs are occurring. As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). SPAC vs. IPO. A distinct feature of SPAC 3.0

M&A

M&A IPO Valuation Mergers and Acquisitions

Why Aren’t More Tire Dealerships Going Public?

Focus Investment Banking

FEBRUARY 25, 2024

The benefits of going public are significant. First, there’s the ability to raise substantial capital by issuing shares to the public in an initial public offering (IPO), as well as secondary offerings. So over the last 30 years, fewer and fewer companies have been going public. Today, the number of U.S.

Private Equity

Private Equity IPO Equities Public Trading

Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions

Cooley M&A

SEPTEMBER 16, 2022

There are compelling rationales for adopting a dual-class structure, but even proponents of the structure generally acknowledge that these benefits are significantly mitigated once the dual-class shares are out of the hands of the founders and/or pre-IPO stockholders. Voting agreements in public M&A transactions.

M&A

M&A IPO Shares Mergers and Acquisitions

SPAC Trend Gives Rise to Securities Enforcement and Litigation Risks

Cooley M&A

MARCH 2, 2021

Special purpose acquisition companies (SPACs) are on the rise. A SPAC is a publicly traded shell company with no underlying operating business that seeks to merge with a target operating company. According to Nasdaq , in 2015, SPACs made up approximately 12% of the IPO market, but by 2020, that number had risen to approximately 53%.

Securities

Securities IPO Mergers and Acquisitions Shares

Cooley’s 2020 Tech M&A Year in Review

Cooley M&A

JANUARY 22, 2021

billion acquisition of Portola and Sunrun’s $3.2 billion combination with Vivint Solar), the remainder of the year played host to a steady stream of acquisitions, with many $10+ billion acquisitions in the second half of the year. Going Public, for the Public. compared to 2019. A SPAC-tacular Year. A Look Ahead.

M&A

M&A IPO Mergers and Acquisitions Business

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A

M&A Mergers and Acquisitions Pharmaceutical Collaboration

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A

M&A Mergers and Acquisitions Pharmaceutical Mergers

Cooley’s 2022 Tech M&A Year in Review

Cooley M&A

JANUARY 25, 2023

The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves.

M&A

M&A Mergers and Acquisitions Private Equity Mergers

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

JANUARY 22, 2025

billion acquisition of Alpine Immune; by contrast, there were eight US biotech acquisitions exceeding $5 billion in 2023. 2024 saw companies focusing on internal research and development, innovative partnerships, and targeted bolt-on asset acquisitions to bolster their pipelines. from 2023. [1]

M&A

M&A Mergers and Acquisitions Pharmaceutical Acquisitions

Investment Banking Today

Sports Investment Banking: How to Win the Super Bowl and the World Cup in the Same Year

Upgrade acquires travel-focused BNPL startup Uplift for a song

Trending Sources

Will There Be an IPO for a Specialty Consulting Company in 2024?

MergersCorp Expands Services to SPAC Companies Amid Growing Market Demand

Investment Banking – Meaning, Functions and More

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Why Aren’t More Tire Dealerships Going Public?

Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions

SPAC Trend Gives Rise to Securities Enforcement and Litigation Risks

Cooley’s 2020 Tech M&A Year in Review

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley’s 2022 Tech M&A Year in Review

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Stay Connected